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Infection is a major problem in intensive care and is associated
with signi¢cant morbidity and mortality [1,2]. Patients with
serious infection often require admission, either from the
community or from another hospital ward. In addition, dura-
tion of stay on the ICU is a major risk factor for nosocomial,
ICU-acquired infection. As patients are increasingly immu-
nosuppressed due to aggressive diagnostic and treatment pro-
tocols, they also become more susceptible to infection. As
more andmore antibiotic is used to overcome these infections,
antibiotic resistance is exacerbated, creating a vicious circle of
exotic antibiotic use and even greater resistance [3].The inten-
sity of antibiotic use is such that, at Aberdeen Royal In¢rmary,
a 1500-bed acute teaching hospital with an eight-bed ICU,
these eight beds consume 10% of the total antibiotic budget.
This is a powerful selection pressure for antibiotic resistance.
T RA I N I N G F O R M U L T I D I S C I P L I N A RY
M A N A G E M E N T O F I N F E C T I O N
ICUs in Europe are usually run by intensivists. While they
should consult closely with all necessary sta¡ in the manage-
ment of infection, they should retain overall executive control
of each patient. To do this properly necessitates extensive
broad-based training, including at least 1year studying infec-
tious diseases and microbiology so that they understand the
fundamental principles of the diagnosis, treatment and control
of infection and can also liaise fully with specialists in infec-
tion. They should manage their infected cases with advice
from microbiologists and infectious disease specialists. The
infection service liaison should include 24 h/day access to
laboratory facilities with at least daily patient review in the
light of laboratory results.
The bene¢ts of close collaboration between intensivists,
clinicians and microbiologists in the area of intensive care
medicine are manifested by successfully designed and imple-
mented antibiotic policies, robust diagnostic approaches to
infection, and e¡ective infection control practices supported
by sound surveillance of infectingmicroorganisms.
A N TI BIOTIC PO LI CIES
The antibiotic management of infection is an important aspect
of intensive caremedicine.
While e¡orts are made to ensure prompt and optimal treat-
ment of infection, antibiotics should be reviewed frequently,
ideally every day, with a view to streamlining to simpler,
sometimes even oral, therapy at the earliest opportunity and to
stopping treatment at the earliest appropriate moment. The
use of automatic stop orders may be appropriate with regard to
selected drugs for speci¢c indications.While written antibio-
tic policies are increasingly being adopted, it is important that
treatment be individualized on the best available knowledge
about that patient, including the patient's origin. For example,
if the patient is transferred from another ICU in a di¡erent
country, empirical antibiotic treatment may di¡er, depending
on particular resistance problems in that country or hospital.
Similarly, patients admitted directly from other hospitals/
countries should be barrier nursed until it has been established
that they are not carrying any unusual, multiresistant organ-
isms. Local, national and international antibiotic resistance
surveillance data play an important role in determining the
correct antibiotic prescription. Antibiotic treatment for criti-
cally ill patients should also make best use of pharmacokinetic
and pharmacodynamic data, with measurement of serum
levels and minimum inhibitory concentrations, where possi-
ble, to ensure both adequate treatment and minimal toxicity
[4]. A daily discussion of cases by a team gathering of intensi-
vists, infectious disease specialists, clinical microbiologists and
pharmacists provides a valuable approach to ensuring optimal
antibiotic management.
More work on antimicrobial use strategies is important,
particularly with a view to reducing the emergence and main-
tenance of resistant organisms [5].While there is no evidence
as yet that rotational prescribing of antibiotics is better than
prescribing on an individual patient basis, in the presence of
outbreaks or endemic resistance with organisms known to be
producers of extended-spectrum b-lactamases or stably
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de-repressed mutants of Enterobacter spp. there is good
evidence that a prescribing embargo of key antibiotics can be
helpful in control. Detection of new resistant mechanisms
must be a priority on ICU specimens, as should monitoring
for emergence of resistance to new antibiotics. A scheme for
rotation of antibiotics is shown in Figure1.
D I A G N O S IS
A goal of the various diagnostic techniques is to achieve the
best-quality specimens, in order to permit the best-informed
decisions to be made about antibiotic prescribing. Not only
does this ensure best treatment of infection, but it also reduces
unnecessary prescriptions, thereby reducing the selective pres-
sure for antibiotic-resistant organisms. One example is the use
of distal sampling techniques, such as bronchoalveolar lavage,
to diagnose ventilator-associated pneumonia [6,7]. This gives
increased speci¢city over culture of endotracheal aspirates
without reducing diagnostic sensitivity and has been shown to
reduce inappropriate antibiotic prescriptions and improve
treatment.
Expert advice on the collection of specimens is often useful,
particularly if the patient is already on antibiotics. Use of
special techniques such as molecular probes may be helpful in
diagnosing infection with di¤cult organisms such as Candida
andAspergillus and rapid detection of resistance. It is important
to recognize that the sepsis syndrome has many causes, includ-
ing endotoxaemia rather than bacteraemia. The former will
not respond to antibiotics.
IN F E C TI O N C O N T R O L
Infection control advice is essential in the management and
prevention of infection in the ICU. Screening of patients and
the environment for selective organisms can be cost-e¡ective
in some situations (Table 1). Multi-site colonization can be a
predictor of invasive infections [7]. In the future, measurement
of pathogenicitymarkers may help in di¡erentiating coloniza-
tion from infection. Molecular typing of organisms in real
time, while expensive, can help in individual patient manage-
ment and also in determining routes of spread, thereby
enabling control measures to be taken in a timely manner.This
is likely to be a fruitful area for research in association with
hospital epidemiologists.
Appropriate infection control techniques and written poli-
cies should exist and be adhered to [8]. Proper sta¤ng of units
is essential for good-quality care, allowing time for careful
performance of infection control procedures, notably includ-
ing handwashing. Appropriate bedside design and housekeep-
ing cleaning schedules for the environment and policies on use
and disinfection of equipment are essential [9,10]. Catheters,
lines and tubing should be managed with appropriate precau-
tions.
All sta¡ in the ICU should be taught sound infection con-
trol practice. There should be e¡ective links with the hospital
epidemiologist and infection control team nurses. Adequate
Figure 1 Suggested scheme for cycling of empirical therapy.
Reserve 4FQs for treatment failure, b-lactam allergy or amino-
glycoside toxicity. Individualize vancomycin as necessary
within local guidelines for its use. Avoid low-activity quino-
lones and oral vancomycin where possible.This is suggested
for empirical treatment of serious sepsis in units where there
are no major, established resistance problems that would pre-
vent the ®rst-line use of one of the three main categories of b-
lactams. Aminoglycosides should be used in combination in
the case of clinical severity or where the need to prevent
emergence of resistant mutants exists. The period of cycling
suggested is 2 months, which should be short enough to pre-
vent emergence of major resistance problems. Abbreviations:
3 or 4 Gceph, third- or fourth-generation cephalosporin; BL/
inhib, b-lactam with b-lactamase inhibitor; 4FQ, 4-¯uoroquino-
lone; 2/12, 2 months' duration. Adapted from Sanders [5], per-
sonal communication.
Table 1 Alert organism for surveillance and barrier precautions
Gram-positive pathogens
Methicillin-resistant Staphylococcus aureus
Glycopeptide-intermediate/resistant S. aureus
Glycopeptide-resistant enterococci
High-level aminoglycoside-resistant enterococci
Gram-negative pathogens
Aminoglycoside-resistant Enterobacteriaceae
Carbapenem-resistant Enterobacteriaceae/Acinetobacter spp.
4GCa-resistant Enterobacteriaceae
Burkholderia cepaciae
Acinetobacter spp. resistant to three drug classesb
Pseudomonas spp. or other non-fermenter resistant to three drug
classesb carbapenem
a4GC, fourth generation cephalosporins; bthird-generation
cephalosporins, aminoglycosides, ¯uoroquinolones.
ããâGould and Carlet Infection services in the intensive care unit
= 2000 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 6, 442±444
isolation facilities and handwashing facilities should be avail-
able, and there should be some single roomswith reversible air
exchange for either positive or negative pressure isolation.
S U R V EI L LA N C E
Surveillance of infection plays an important role in monitor-
ing the infectious burden.This should include microbiological
surveillance of Alert organisms (Table 1) as well as surveillance
of more speci¢c, clinically proven infection. Computerization
will also allow more e¤cient £agging of patients who carry
Alert organisms or are suspected to have a nosocomial infec-
tion. It will also allow better audit of procedures and out-
comes. Audit should be ongoing, with completion of audit
cycles and continual re-examination of services, priorities and
outcomes.
In conclusion, the ¢ne balance between the patient's endo-
genous £ora and the microbial ecology of the ICU can readily
be disturbed and result in the infection burden of ICU. Care
demands close cooperation between intensivists, clinicians
and microbiologists. Great care should be taken with all
aspects of infection control.With the increasing problem of
antibiotic resistance, there is an urgent need to improve our
use of antibiotics by better de¢ning the nature of infection in
the ICU. By the adoption of such good clinical practice, care
within the ICU can be made safer. The present blunderbuss
approach to treatment is often harmful, interfering with
endogenous £ora and themicrobial ecologyof the ICU.
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